Camille Lenoir
9PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 04, 2025
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban.Frédéric Gaspar, Jean Terrier, Celestin Jacot-Descombes
|Oct 05, 2023
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.Jean Terrier, Frédéric Gaspar, Pauline Gosselin
|Sep 19, 2023
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.Frédéric Gaspar, Jean Terrier, Samantha Favre
|Apr 23, 2022
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting.Camille Lenoir, Jean Terrier, Yvonne Gloor
|Aug 31, 2021
Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review.Camille Lenoir, Frédérique Rodieux, Jules A Desmeules
|Apr 03, 2021
Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase.Silvia Fernandez, Camille Lenoir, Caroline Flora Samer
Pageof 2
Frequent Collaborators
5 joint publications
Victoria Rollason
4 joint publications
Caroline Samer
4 joint publications
Jean Terrier
3 joint publications
Frédéric Gaspar
3 joint publications
Pierre Fontana
2 joint publications
Youssef Daali
1 joint publications
Silvia Fernandez
1 joint publications
Frédérique Rodieux
1 joint publications
Jules A Desmeules
1 joint publications
Chantal Csajka
